@lenawirth.bsky.social
Reposted
Is there anything more fun than starting your talk with a walk-up song?! Thank you to the brilliant 3rd year Immunobiology PhD students at Yale who organized the '12th Yale Immunobiology Student Symposium' today. @sofivieto.bsky.social
April 16, 2025 at 10:43 PM
Is there anything more fun than starting your talk with a walk-up song?! Thank you to the brilliant 3rd year Immunobiology PhD students at Yale who organized the '12th Yale Immunobiology Student Symposium' today. @sofivieto.bsky.social
Reposted
I'm proud to have been a part of the team that worked on this project! Miya, @lenawirth.bsky.social, and @braunmdphd.bsky.social are all brilliant collaborators and an incredibly fun group to talk science with!
1/Excited to share our latest work in Cancer Discovery @theaacr.bsky.social. Led with #MiyaHugaboom and @kstreet.bsky.social, we show that the presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical responses to PD-1 blockade in #RCC: brnw.ch/21wQUU4
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
Abstract. Immune checkpoint inhibitors (ICI) targeting the PD-1 pathway have transformed treatment of advanced renal cell carcinoma (RCC), but mechanisms underlying therapeutic response remain largely...
brnw.ch
February 25, 2025 at 8:58 PM
I'm proud to have been a part of the team that worked on this project! Miya, @lenawirth.bsky.social, and @braunmdphd.bsky.social are all brilliant collaborators and an incredibly fun group to talk science with!
1/Excited to share our latest work in Cancer Discovery @theaacr.bsky.social. Led with #MiyaHugaboom and @kstreet.bsky.social, we show that the presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical responses to PD-1 blockade in #RCC: brnw.ch/21wQUU4
Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma
Abstract. Immune checkpoint inhibitors (ICI) targeting the PD-1 pathway have transformed treatment of advanced renal cell carcinoma (RCC), but mechanisms underlying therapeutic response remain largely...
brnw.ch
February 25, 2025 at 5:45 PM
1/Excited to share our latest work in Cancer Discovery @theaacr.bsky.social. Led with #MiyaHugaboom and @kstreet.bsky.social, we show that the presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical responses to PD-1 blockade in #RCC: brnw.ch/21wQUU4